Related Experiment Video
Updated: Oct 16, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2
Boshi Yu1, Mengmeng Li1, Shu Ping Han1
1Department of Pediatrics, Women's Hospital of Nanjing Medical University Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu 210004, P.R. China.
Insights
Hsa_circ_105039, underexpressed in congenital heart disease (CHD), promotes cardiomyocyte differentiation and viability. It acts as a sponge for miR-17, targeting cyclinD2, offering a protective effect in iPS cell-derived cardiomyocytes.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Molecular Medicine
Background:
- Hsa_circ_105039 is underexpressed in congenital heart disease (CHD) patient heart tissue.
- The precise function and molecular mechanisms of hsa_circ_105039 in CHD remain largely unknown.
Purpose of the Study:
- To investigate the role and mechanism of hsa_circ_105039 in the context of CHD using induced pluripotent stem (iPS) cell-derived cardiomyocytes.
- To explore the potential of hsa_circ_105039 as a diagnostic marker for CHD.
Main Methods:
- Induced pluripotent stem (iPS) cells were differentiated into cardiomyocytes using dimethyl sulfoxide (DMSO).
- Hsa_circ_105039 knockdown and overexpression were performed to assess effects on cell differentiation, viability, migration, and apoptosis.
- Luciferase reporter assays were used to identify microRNA (miR) interactions.
- Reverse transcription-quantitative PCR and western blotting were employed to analyze gene and protein expression.
Main Results:
- Hsa_circ_105039 overexpression enhanced cardiomyocyte differentiation, viability, and migration while reducing apoptosis.
- Hsa_circ_105039 functions as a molecular sponge for miR-17, with cyclinD2 identified as a direct target of miR-17.
- Hsa_circ_105039 upregulated differentiation-related genes and proteins, including natriuretic peptide A, cardiac troponin I, GATA-binding protein 4, and a homobox transcription factor.
Conclusions:
- Hsa_circ_105039 exerts a protective effect in DMSO-induced iPS cell-derived cardiomyocytes by promoting the miR-17/cyclinD2 pathway.
- Hsa_circ_105039 represents a potential key molecule for the diagnosis of congenital heart disease.
Abstract:
Previously it was found that hsa_circ_105039 was underexpressed in the heart tissue of patients with congenital heart disease (CHD). However, the function and mechanism of hsa_circ_105039 in CHD are unclear. In the present study, induced pluripotent stem (iPS) cells were differentiated into cardiomyocytes using 1% dimethyl sulfoxide (DMSO). Cell differentiation, viability, migration and apoptosis were measured before and following hsa_circ_105039 knockdown or overexpression. The results indicated that hsa_circ_105039 overexpression promoted cell differentiation, viability and migration; whereas apoptosis was simultaneously repressed. A luciferase reporter assay verified that hsa_circ_105039 acted as a sponge for microRNA (miR)‑17 and that cyclinD2 was a direct target of miR‑17. Furthermore, differentiation‑related genes and proteins were analyzed by reverse transcription‑quantitative PCR and western blotting, respectively. The results showed that hsa_circ_105039 could also upregulate the expression of differentiation‑related genes and proteins, including natriuretic peptide A, cardiac troponin I, GATA‑binding protein 4 and homobox transcription factor, in iPS cells. The results suggested that hsa_circ_105039 exerted a protective effect by promoting miR‑17/cyclinD2 in DMSO‑induced iPS cardiomyocytes, which indicated that hsa_circ_105039 is a potential key molecule for the diagnosis of CHD.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Positive Regulator Molecules
Experimental RNAi
Inhibition of Cdk Activity
MicroRNAs
Abnormal Proliferation

